Andrew E. Parker
Impact in
- Immunology top 5%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
-
- Biochemical and Molecular Research 5
- DNA Repair Mechanisms 4
- Wnt/β-catenin signaling in development and cancer 4
-
- Protease and Inhibitor Mechanisms 7
- Co-authors
- Luke O'neill (2 shared papers)Elizabeth J. Hennessy (1 shared paper)Ian M. Clark (7 shared papers)Brian Keogh (3 shared papers)Inez Van de Weyer (4 shared papers)Walter Luyten (3 shared papers)Marc C. Laus (4 shared papers)William McCormack (3 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Matrix Biology (2 papers)Journal of the American Institute for Conservation (2 papers)Osteoarthritis and Cartilage (2 papers)Expert Opinion on Therapeutic Targets (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Andrew E. Parker
35 papers receiving 2.8k citations
Andrew E. Parker's Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 823
- Cancer Research 436
- Rheumatology 378
- Immunology and Allergy 127
- Cell Biology 364
Countries citing papers authored by Andrew E. Parker
This map shows the geographic impact of Andrew E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Parker more than expected).
Fields of papers citing papers by Andrew E. Parker
This network shows the impact of papers produced by Andrew E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Parker. The network helps show where Andrew E. Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew E. Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Toll-like receptors: emerging therapeutics? Hit paper breakdown → | 2010 | 712 |
| 2 | 2004 | 332 | |
| 3 | 1999 | 238 | |
| 4 | 2012 | 231 | |
| 5 | 1991 | 163 | |
| 6 | 2010 | 149 | |
| 7 | 1991 | 99 | |
| 8 | 1998 | 92 | |
| 9 | 2011 | 70 | |
| 10 | 2014 | 70 | |
| 11 | 1998 | 69 | |
| 12 | 2007 | 68 | |
| 13 | 2009 | 66 | |
| 14 | 2003 | 65 | |
| 15 | 1991 | 60 | |
| 16 | 2011 | 49 | |
| 17 | 1997 | 42 | |
| 18 | 2005 | 33 | |
| 19 | 2009 | 31 | |
| 20 | 2009 | 29 |
About Andrew E. Parker
Andrew E. Parker is a scholar working on Molecular Biology, Cancer Research, Immunology, Rheumatology and Immunology and Allergy, having authored 37 papers that have together received 2.8k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Protease and Inhibitor Mechanisms (7 papers), Cell Adhesion Molecules Research (6 papers), Immune Response and Inflammation (6 papers), Biochemical and Molecular Research (5 papers), DNA Repair Mechanisms (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). The work is most often cited by research in Immunology (823 citations), Cancer Research (436 citations), Rheumatology (378 citations), Immunology and Allergy (127 citations) and Cell Biology (364 citations). Andrew E. Parker has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Luke O'neill, Elizabeth J. Hennessy, Ian M. Clark, Brian Keogh, Inez Van de Weyer, Walter Luyten, Marc C. Laus, William McCormack, Lara Kevorkian and Grant N. Wheeler. Their work appears in journals such as Journal of Biological Chemistry, Matrix Biology, Journal of the American Institute for Conservation, Osteoarthritis and Cartilage and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.